Castle Creek to collaborate with Mayo Clinic on developing new gene therapies for rare diseases

Castle Creek Biosciences Inc. is teaming up with the Mayo Clinic to advance the development of potential gene therapies for two rare genetic connective tissue disorders. "We expect this initiative will be the first of multiple Castle Creek strategic collaborations with leading medical research institutions that have the potential to expand our innovative gene therapy discoveries for rare diseases," said Matthew Gantz, CEO of Castle Creek Biosciences. The partners hip will focus on the discovery…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news